
Vaximm goes East for cancer vaccine deal
T-cell immunotherapy expert Vaximm plans to use Artificial Intelligence (AI) to develop personalised cancer vaccines. The biotech is collaboration...

Rotavirus vaccines kill cancer cells
The team headed by Aurelian Marabelle discovered in mice that commercially available vaccines against rotavirus – which causes diarrhea in children...

Magenta Therapeutics exercises ATAC licence option
Stem cell specialist Magenta Therapeutics (Cambridge, MA, USA) agreed to pay up to $85m in milestones for the rights to exclusively develop and...

AMR: GARDP and Entasis Therapeutics start pivotal study
In the open-label study enroling 1,000 patients, safety and efficacy of zoliflodacin will be compared with a combination of azithromycin and...

GHO capital launches EU's largest fund ever for life sciences
Global Healthcare Opportunities, or GHO Capital Partners LLP said that its finally closed Fund II will be focussed on high growth healthcare...

Healx Ltd raises $56m in Series B financing
The financing was led by Atomico and joined by Intel Capital, Global Brain and btov Partners as new investors. Existing investors from a US$10m...

Test detects breast cancer in earliest stage
The new research results were presented at the 2019 NCRI Cancer Conference today by Daniyah Alfattani from National Cancer Research Institute (NCRI)...